Nobel laureate Jennifer Doudna on CRISPR and the future of gene editing

Nobel laureate Jennifer Doudna shares the untold story of CRISPR's Berkeley roots, from casual cafe chats sparking bacterial immune insights to today's FDA-approved sickle cell cures and in-vivo editing breakthroughs. She envisions gene editing's future tackling rare diseases affordably while navigating ethics, equity, and global access through the Innovative Genomics Institute. Read the full article and listen to the talk here.